| FUJI CHEMICAL INDUSTRY CO., LTD. Patent applications |
| Patent application number | Title | Published |
|---|
| 20120040001 | DISINTEGRATING PARTICLE COMPOSITION AND RAPIDLY DISINTEGRATING COMPRESSION-MOLDED MATERIAL USED THE SAME - [Subject Matter] | 02-16-2012 |
| 20120004297 | Agent for alleviating vascular failure - An agent for alleviating, treating and preventing vascular failure and a vascular endothelial cell-protecting agent characterized by containing, as an effective ingredient, at least one active oxygen scavenger such as astaxanthin and tocotrienols; and a food, a drink and an animal feed having an effect of alleviating, treating and preventing vascular failure and an effect of protecting vascular endothelial cells characterized by containing, as the effective ingredient, at least one active oxygen scavenger such as astaxanthin and tocotrienols. | 01-05-2012 |
| 20110091546 | COMPOSITION FOR RAPID DISINTEGRATING TABLET IN ORAL CAVITY - The present invention provides rapid disintegrating tablets in oral cavity having a shortened disintegration time in oral cavity as well as a sufficient hardness with compared to rapid disintegrating tablets of the prior art. | 04-21-2011 |
| 20110077307 | ASTAXANTHIN-CONTAINING PET FOODS - There is provided pet food comprising astaxanthin and/or an ester thereof as an active component and having an effect of deodorizing excrement such as urine and feces, effects of improving sleep, sensibility such as perception and cognition, and visual sense, and an effect of treating, improving or preventing diabetes and diabetic complications. The pet food can deodorize excrement such as urine and feces, improve sleep, sensibility such as perception and cognition, and visual sense, and treat, improve or prevent diabetes and diabetic complications. | 03-31-2011 |
| 20100204523 | METHOD OF PREVENTING DISCOLORATION OF CAROTENOID PIGMENT AND CONTAINER USED THEREFOR - The method includes storing a carotenoid pigment in a container that has an average spectral transmittance of 0.01 to 45.0% at a wavelength of 535 to 695 nm. | 08-12-2010 |
| 20080269349 | Gene expression regulating agent - An object of the invention is to provide a gene expression regulating agent which includes astaxanthin and/or its ester as an effective ingredient; and a food and drink having an effect of regulating gene expression which includes astaxanthin and/or its ester. Abnormal gene expression due to, for example, oxidative stress can be treated, improved, and/or prevented, and diseases caused by the abnormal gene expression can be treated, improved, and/or prevented. A gene expression regulating agent which includes astaxanthin and/or its ester as an effective ingredient; and a food and drink having an effect of regulating gene expression which includes astaxanthin and/or its ester are provided and are useful for treating, improving, and/or preventing the symptom caused by the abnormal gene expression, that is, excessive expression or suppression of expression. | 10-30-2008 |
